171 related articles for article (PubMed ID: 15902740)
1. Syndecan-1 and E-cadherin expression in differentiated type of early gastric cancer.
Huang MF; Zhu YQ; Chen ZF; Xiao J; Huang X; Xiong YY; Yang GF
World J Gastroenterol; 2005 May; 11(19):2975-80. PubMed ID: 15902740
[TBL] [Abstract][Full Text] [Related]
2. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
[TBL] [Abstract][Full Text] [Related]
3. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies.
Mitselou A; Ioachim E; Peschos D; Charalabopoulos K; Michael M; Agnantis NJ; Vougiouklakis T
Exp Oncol; 2007 Mar; 29(1):54-60. PubMed ID: 17431390
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of peroxisome proliferator-activated receptor in histologically different human gastric cancer tissues.
Nomura S; Nakajima A; Ishimine S; Matsuhashi N; Kadowaki T; Kaminishi M
J Exp Clin Cancer Res; 2006 Sep; 25(3):443-8. PubMed ID: 17167986
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
[TBL] [Abstract][Full Text] [Related]
7. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
8. Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis.
Mingchao ; Devereux TR; Stockton P; Sun K; Sills RC; Clayton N; Portier M; Flake G
Exp Toxicol Pathol; 2001 Sep; 53(4):237-46. PubMed ID: 11665847
[TBL] [Abstract][Full Text] [Related]
9. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
10. Localization of syndecan-1 in human gastric mucosa associated with ulceration.
Tanabe H; Yokota K; Kohgo Y
J Pathol; 1999 Feb; 187(3):338-44. PubMed ID: 10398089
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin expression as a differentiation marker in gastric cancer.
Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Karatzas G
Hepatogastroenterology; 1998; 45(24):2437-42. PubMed ID: 9951940
[TBL] [Abstract][Full Text] [Related]
12. The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma.
Bayer-Garner IB; Smoller BR
J Cutan Pathol; 2001 Feb; 28(2):83-9. PubMed ID: 11168756
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer.
Fujiya M; Watari J; Ashida T; Honda M; Tanabe H; Fujiki T; Saitoh Y; Kohgo Y
Jpn J Cancer Res; 2001 Oct; 92(10):1074-81. PubMed ID: 11676858
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.
Zhou YN; Xu CP; Han B; Li M; Qiao L; Fang DC; Yang JM
World J Gastroenterol; 2002 Dec; 8(6):987-93. PubMed ID: 12439911
[TBL] [Abstract][Full Text] [Related]
15. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion.
Maehata Y; Hirahashi M; Aishima S; Kishimoto J; Hirohashi S; Yao T; Takashima H; Tsuneyoshi M; Oda Y
Hum Pathol; 2011 Apr; 42(4):558-67. PubMed ID: 21239043
[TBL] [Abstract][Full Text] [Related]
16. Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer.
Wiksten JP; Lundin J; Nordling S; Lundin M; Kokkola A; von Boguslawski K; Haglund C
Int J Cancer; 2001 Jan; 95(1):1-6. PubMed ID: 11241302
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of CD147 and E-cadherin in human gastric carcinoma].
Wang LL; Yao GY; Zhang BY; Zhang XM; Zhao M
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):515-9. PubMed ID: 19950699
[TBL] [Abstract][Full Text] [Related]
18. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas.
Nakamura E; Sugihara H; Bamba M; Hattori T
J Pathol; 2005 Feb; 205(3):349-58. PubMed ID: 15682444
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Expression of Cell Adhesion Molecule Markers (E-Cadherin and Syndecan-1) between Young and Older Age Patients with Gastric Carcinoma.
Geramizadeh B; Adeli OA; Rahsaz M; Mokhtari M; Sefidbakht S
J Gastrointest Cancer; 2010 Sep; 41(3):193-6. PubMed ID: 20393887
[TBL] [Abstract][Full Text] [Related]
20. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]